Oncternal Therapeutics shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of Oncternal Therapeutics shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in Oncternal Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Oncternal Therapeutics held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Oncternal Therapeutics by Jpmorgan Chase & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $10k | 20k | 0.52 |
| 2023-09-30 | $6.0k | 20k | 0.30 |
| 2023-06-30 | $8 | 27 | 0.33 |
| 2023-03-31 | $0 | 27 | 0.00 |
| 2022-12-31 | $0 | 27 | 0.00 |
| 2022-06-30 | $0 | 27 | 0.00 |
| 2022-03-31 | $29k | 21k | 1.40 |
| 2021-12-31 | $48k | 21k | 2.30 |
| 2021-03-31 | $2.0k | 241 | 8.30 |
| 2020-09-30 | $0 | 7 | 0.00 |
| 2020-06-30 | $0 | 7 | 0.00 |
| 2019-09-30 | $0 | 63 | 0.00 |